APO Research
Talk to an analyst

APO RESEARCH · REPORT

Psychiatric API

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Psychiatric API Market Analysis and Forecast 2026-2032

22 December 2025208 pages

Choose your research edition.

Industry ResearchPsychiatric API Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Psychiatric API Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Psychiatric API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Psychiatric API Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Psychiatric API Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Psychiatric API market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Psychiatric API is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Psychiatric API is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Psychiatric API is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Psychiatric API is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Psychiatric API include Yaopharma, Yangtze River Pharmaceutical, Sichuan Chuanda West China Pharmaceutical, Ren An Pharmaceutical, Eli Lilly, Kanghong Pharmaceutical, Pfizer, Huahai Pharmaceutical and Hengrui Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Psychiatric API, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Psychiatric API, also provides the sales of main regions and countries. Of the upcoming market potential for Psychiatric API, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Psychiatric API sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Psychiatric API market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Psychiatric API sales, projected growth trends, production technology, application and end-user industry.

Psychiatric API Segment by Company

Yaopharma

Yangtze River Pharmaceutical

Sichuan Chuanda West China Pharmaceutical

Ren An Pharmaceutical

Eli Lilly

Kanghong Pharmaceutical

Pfizer

Huahai Pharmaceutical

Hengrui Pharmaceuticals

Herui Pharmaceutical

Dongting Pharmaceutical

Brilliant Pharmaceutical

Salutas Pharma

Germany Pharmaceutical

Dr.Reddy's Laboratories

Bora Pharmaceutical

Psychiatric API Segment by Type

Venlafaxine

Paroxetine

Duloxetine

Olanzapine

Others

Psychiatric API Segment by Application

Generalized Anxiety Disorder

Schizophrenia

Fibromyalgia

Major Depressive Disorder

Others

Psychiatric API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Psychiatric API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Psychiatric API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Psychiatric API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Psychiatric API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Psychiatric API manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Psychiatric API sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Psychiatric API Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Venlafaxine Major Manufacturers Table 3. Paroxetine Major Manufacturers Table 4. Duloxetine Major Manufacturers Table 5. Olanzapine Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Psychiatric API Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Generalized Anxiety Disorder Major Manufacturers Table 9. Schizophrenia Major Manufacturers Table 10. Fibromyalgia Major Manufacturers Table 11. Major Depressive Disorder Major Manufacturers Table 12. Others Major Manufacturers Table 13. Psychiatric API Industry Trends Table 14. Psychiatric API Industry Drivers Table 15. Psychiatric API Industry Opportunities and Challenges Table 16. Psychiatric API Industry Restraints Table 17. Global Psychiatric API Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Psychiatric API Revenue by Region (2021-2026) & (US$ Million) Table 19. Global Psychiatric API Revenue by Region (2027-2032) & (US$ Million) Table 20. Global Psychiatric API Revenue Market Share by Region (2021-2026) Table 21. Global Psychiatric API Revenue Market Share by Region (2027-2032) Table 22. Global Psychiatric API Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 23. Global Psychiatric API Sales by Region (2021-2026) & (k units) Table 24. Global Psychiatric API Sales by Region (2027-2032) & (k units) Table 25. Global Psychiatric API Sales Market Share by Region (2021-2026) Table 26. Global Psychiatric API Sales Market Share by Region (2027-2032) Table 27. Global Psychiatric API Revenue by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Psychiatric API Revenue Market Share by Manufacturers (2021-2026) Table 29. Global Psychiatric API Sales by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Psychiatric API Sales Market Share by Manufacturers (2021-2026) Table 31. Global Psychiatric API Sales Price (US$/unit) of Manufacturers (2021-2026) Table 32. Global Psychiatric API Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 33. Global Psychiatric API Key Manufacturers Manufacturing Sites & Headquarters Table 34. Global Psychiatric API Manufacturers, Product Type & Application Table 35. Global Psychiatric API Manufacturers' Establishment Date Table 36. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 37. Global Psychiatric API by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 38. Global Psychiatric API Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Psychiatric API Revenue by Type (2021-2026) & (US$ Million) Table 40. Global Psychiatric API Revenue by Type (2027-2032) & (US$ Million) Table 41. Global Psychiatric API Revenue Market Share by Type (2021-2026) Table 42. Global Psychiatric API Revenue Market Share by Type (2027-2032) Table 43. Global Psychiatric API Sales by Type 2021 VS 2025 VS 2032 (k units) Table 44. Global Psychiatric API Sales by Type (2021-2026) & (k units) Table 45. Global Psychiatric API Sales by Type (2027-2032) & (k units) Table 46. Global Psychiatric API Sales Market Share by Type (2021-2026) Table 47. Global Psychiatric API Sales Market Share by Type (2027-2032) Table 48. Global Psychiatric API Price by Type (2021-2026) & (US$/unit) Table 49. Global Psychiatric API Price by Type (2027-2032) & (US$/unit) Table 50. Global Psychiatric API Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Psychiatric API Revenue by Application (2021-2026) & (US$ Million) Table 52. Global Psychiatric API Revenue by Application (2027-2032) & (US$ Million) Table 53. Global Psychiatric API Revenue Market Share by Application (2021-2026) Table 54. Global Psychiatric API Revenue Market Share by Application (2027-2032) Table 55. Global Psychiatric API Sales by Application 2021 VS 2025 VS 2032 (k units) Table 56. Global Psychiatric API Sales by Application (2021-2026) & (k units) Table 57. Global Psychiatric API Sales by Application (2027-2032) & (k units) Table 58. Global Psychiatric API Sales Market Share by Application (2021-2026) Table 59. Global Psychiatric API Sales Market Share by Application (2027-2032) Table 60. Global Psychiatric API Price by Application (2021-2026) & (US$/unit) Table 61. Global Psychiatric API Price by Application (2027-2032) & (US$/unit) Table 62. Yaopharma Company Information Table 63. Yaopharma Business Overview Table 64. Yaopharma Psychiatric API Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 65. Yaopharma Psychiatric API Product Portfolio Table 66. Yaopharma Recent Development Table 67. Yangtze River Pharmaceutical Company Information Table 68. Yangtze River Pharmaceutical Business Overview Table 69. Yangtze River Pharmaceutical Psychiatric API Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. Yangtze River Pharmaceutical Psychiatric API Product Portfolio Table 71. Yangtze River Pharmaceutical Recent Development Table 72. Sichuan Chuanda West China Pharmaceutical Company Information Table 73. Sichuan Chuanda West China Pharmaceutical Business Overview Table 74. Sichuan Chuanda West China Pharmaceutical Psychiatric API Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Sichuan Chuanda West China Pharmaceutical Psychiatric API Product Portfolio Table 76. Sichuan Chuanda West China Pharmaceutical Recent Development Table 77. Ren An Pharmaceutical Company Information Table 78. Ren An Pharmaceutical Business Overview Table 79. Ren An Pharmaceutical Psychiatric API Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Ren An Pharmaceutical Psychiatric API Product Portfolio Table 81. Ren An Pharmaceutical Recent Development Table 82. Eli Lilly Company Information Table 83. Eli Lilly Business Overview Table 84. Eli Lilly Psychiatric API Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Eli Lilly Psychiatric API Product Portfolio Table 86. Eli Lilly Recent Development Table 87. Kanghong Pharmaceutical Company Information Table 88. Kanghong Pharmaceutical Business Overview Table 89. Kanghong Pharmaceutical Psychiatric API Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Kanghong Pharmaceutical Psychiatric API Product Portfolio Table 91. Kanghong Pharmaceutical Recent Development Table 92. Pfizer Company Information Table 93. Pfizer Business Overview Table 94. Pfizer Psychiatric API Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Pfizer Psychiatric API Product Portfolio Table 96. Pfizer Recent Development Table 97. Huahai Pharmaceutical Company Information Table 98. Huahai Pharmaceutical Business Overview Table 99. Huahai Pharmaceutical Psychiatric API Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Huahai Pharmaceutical Psychiatric API Product Portfolio Table 101. Huahai Pharmaceutical Recent Development Table 102. Hengrui Pharmaceuticals Company Information Table 103. Hengrui Pharmaceuticals Business Overview Table 104. Hengrui Pharmaceuticals Psychiatric API Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Hengrui Pharmaceuticals Psychiatric API Product Portfolio Table 106. Hengrui Pharmaceuticals Recent Development Table 107. Herui Pharmaceutical Company Information Table 108. Herui Pharmaceutical Business Overview Table 109. Herui Pharmaceutical Psychiatric API Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Herui Pharmaceutical Psychiatric API Product Portfolio Table 111. Herui Pharmaceutical Recent Development Table 112. Dongting Pharmaceutical Company Information Table 113. Dongting Pharmaceutical Business Overview Table 114. Dongting Pharmaceutical Psychiatric API Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. Dongting Pharmaceutical Psychiatric API Product Portfolio Table 116. Dongting Pharmaceutical Recent Development Table 117. Brilliant Pharmaceutical Company Information Table 118. Brilliant Pharmaceutical Business Overview Table 119. Brilliant Pharmaceutical Psychiatric API Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 120. Brilliant Pharmaceutical Psychiatric API Product Portfolio Table 121. Brilliant Pharmaceutical Recent Development Table 122. Salutas Pharma Company Information Table 123. Salutas Pharma Business Overview Table 124. Salutas Pharma Psychiatric API Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 125. Salutas Pharma Psychiatric API Product Portfolio Table 126. Salutas Pharma Recent Development Table 127. Germany Pharmaceutical Company Information Table 128. Germany Pharmaceutical Business Overview Table 129. Germany Pharmaceutical Psychiatric API Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 130. Germany Pharmaceutical Psychiatric API Product Portfolio Table 131. Germany Pharmaceutical Recent Development Table 132. Dr.Reddy's Laboratories Company Information Table 133. Dr.Reddy's Laboratories Business Overview Table 134. Dr.Reddy's Laboratories Psychiatric API Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 135. Dr.Reddy's Laboratories Psychiatric API Product Portfolio Table 136. Dr.Reddy's Laboratories Recent Development Table 137. Bora Pharmaceutical Company Information Table 138. Bora Pharmaceutical Business Overview Table 139. Bora Pharmaceutical Psychiatric API Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 140. Bora Pharmaceutical Psychiatric API Product Portfolio Table 141. Bora Pharmaceutical Recent Development Table 142. North America Psychiatric API Revenue by Type (2021-2026) & (US$ Million) Table 143. North America Psychiatric API Revenue by Type (2027-2032) & (US$ Million) Table 144. North America Psychiatric API Sales by Type (2021-2026) & (k units) Table 145. North America Psychiatric API Sales by Type (2027-2032) & (k units) Table 146. North America Psychiatric API Sales Price by Type (2021-2026) & (US$/unit) Table 147. North America Psychiatric API Sales Price by Type (2027-2032) & (US$/unit) Table 148. North America Psychiatric API Revenue by Application (2021-2026) & (US$ Million) Table 149. North America Psychiatric API Revenue by Application (2027-2032) & (US$ Million) Table 150. North America Psychiatric API Sales by Application (2021-2026) & (k units) Table 151. North America Psychiatric API Sales by Application (2027-2032) & (k units) Table 152. North America Psychiatric API Sales Price by Application (2021-2026) & (US$/unit) Table 153. North America Psychiatric API Sales Price by Application (2027-2032) & (US$/unit) Table 154. North America Psychiatric API Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 155. North America Psychiatric API Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 156. North America Psychiatric API Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 157. North America Psychiatric API Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 158. North America Psychiatric API Sales by Country (2021-2026) & (k units) Table 159. North America Psychiatric API Sales by Country (2027-2032) & (k units) Table 160. North America Psychiatric API Sales Price by Country (2021-2026) & (US$/unit) Table 161. North America Psychiatric API Sales Price by Country (2027-2032) & (US$/unit) Table 162. United States Psychiatric API Revenue (2021-2032) & (US$ Million) Table 163. Canada Psychiatric API Revenue (2021-2032) & (US$ Million) Table 164. Mexico Psychiatric API Revenue (2021-2032) & (US$ Million) Table 165. Europe Psychiatric API Revenue by Type (2021-2026) & (US$ Million) Table 166. Europe Psychiatric API Revenue by Type (2027-2032) & (US$ Million) Table 167. Europe Psychiatric API Sales by Type (2021-2026) & (k units) Table 168. Europe Psychiatric API Sales by Type (2027-2032) & (k units) Table 169. Europe Psychiatric API Sales Price by Type (2021-2026) & (US$/unit) Table 170. Europe Psychiatric API Sales Price by Type (2027-2032) & (US$/unit) Table 171. Europe Psychiatric API Revenue by Application (2021-2026) & (US$ Million) Table 172. Europe Psychiatric API Revenue by Application (2027-2032) & (US$ Million) Table 173. Europe Psychiatric API Sales by Application (2021-2026) & (k units) Table 174. Europe Psychiatric API Sales by Application (2027-2032) & (k units) Table 175. Europe Psychiatric API Sales Price by Application (2021-2026) & (US$/unit) Table 176. Europe Psychiatric API Sales Price by Application (2027-2032) & (US$/unit) Table 177. Europe Psychiatric API Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 178. Europe Psychiatric API Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 179. Europe Psychiatric API Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 180. Europe Psychiatric API Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 181. Europe Psychiatric API Sales by Country (2021-2026) & (k units) Table 182. Europe Psychiatric API Sales by Country (2027-2032) & (k units) Table 183. Europe Psychiatric API Sales Price by Country (2021-2026) & (US$/unit) Table 184. Europe Psychiatric API Sales Price by Country (2027-2032) & (US$/unit) Table 185. Germany Psychiatric API Revenue (2021-2032) & (US$ Million) Table 186. France Psychiatric API Revenue (2021-2032) & (US$ Million) Table 187. U.K. Psychiatric API Revenue (2021-2032) & (US$ Million) Table 188. Italy Psychiatric API Revenue (2021-2032) & (US$ Million) Table 189. Russia Psychiatric API Revenue (2021-2032) & (US$ Million) Table 190. Spain Psychiatric API Revenue (2021-2032) & (US$ Million) Table 191. Netherlands Psychiatric API Revenue (2021-2032) & (US$ Million) Table 192. Switzerland Psychiatric API Revenue (2021-2032) & (US$ Million) Table 193. Sweden Psychiatric API Revenue (2021-2032) & (US$ Million) Table 194. Poland Psychiatric API Revenue (2021-2032) & (US$ Million) Table 195. China Psychiatric API Revenue by Type (2021-2026) & (US$ Million) Table 196. China Psychiatric API Revenue by Type (2027-2032) & (US$ Million) Table 197. China Psychiatric API Sales by Type (2021-2026) & (k units) Table 198. China Psychiatric API Sales by Type (2027-2032) & (k units) Table 199. China Psychiatric API Sales Price by Type (2021-2026) & (US$/unit) Table 200. China Psychiatric API Sales Price by Type (2027-2032) & (US$/unit) Table 201. China Psychiatric API Revenue by Application (2021-2026) & (US$ Million) Table 202. China Psychiatric API Revenue by Application (2027-2032) & (US$ Million) Table 203. China Psychiatric API Sales by Application (2021-2026) & (k units) Table 204. China Psychiatric API Sales by Application (2027-2032) & (k units) Table 205. China Psychiatric API Sales Price by Application (2021-2026) & (US$/unit) Table 206. China Psychiatric API Sales Price by Application (2027-2032) & (US$/unit) Table 207. Asia Psychiatric API Revenue by Type (2021-2026) & (US$ Million) Table 208. Asia Psychiatric API Revenue by Type (2027-2032) & (US$ Million) Table 209. Asia Psychiatric API Sales by Type (2021-2026) & (k units) Table 210. Asia Psychiatric API Sales by Type (2027-2032) & (k units) Table 211. Asia Psychiatric API Sales Price by Type (2021-2026) & (US$/unit) Table 212. Asia Psychiatric API Sales Price by Type (2027-2032) & (US$/unit) Table 213. Asia Psychiatric API Revenue by Application (2021-2026) & (US$ Million) Table 214. Asia Psychiatric API Revenue by Application (2027-2032) & (US$ Million) Table 215. Asia Psychiatric API Sales by Application (2021-2026) & (k units) Table 216. Asia Psychiatric API Sales by Application (2027-2032) & (k units) Table 217. Asia Psychiatric API Sales Price by Application (2021-2026) & (US$/unit) Table 218. Asia Psychiatric API Sales Price by Application (2027-2032) & (US$/unit) Table 219. Asia Psychiatric API Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 220. Asia Psychiatric API Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 221. Asia Psychiatric API Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 222. Asia Psychiatric API Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 223. Asia Psychiatric API Sales by Country (2021-2026) & (k units) Table 224. Asia Psychiatric API Sales by Country (2027-2032) & (k units) Table 225. Asia Psychiatric API Sales Price by Country (2021-2026) & (US$/unit) Table 226. Asia Psychiatric API Sales Price by Country (2027-2032) & (US$/unit) Table 227. Japan Psychiatric API Revenue (2021-2032) & (US$ Million) Table 228. South Korea Psychiatric API Revenue (2021-2032) & (US$ Million) Table 229. India Psychiatric API Revenue (2021-2032) & (US$ Million) Table 230. Australia Psychiatric API Revenue (2021-2032) & (US$ Million) Table 231. Taiwan Psychiatric API Revenue (2021-2032) & (US$ Million) Table 232. Southeast Asia Psychiatric API Revenue (2021-2032) & (US$ Million) Table 233. SAMEA Psychiatric API Revenue by Type (2021-2026) & (US$ Million) Table 234. SAMEA Psychiatric API Revenue by Type (2027-2032) & (US$ Million) Table 235. SAMEA Psychiatric API Sales by Type (2021-2026) & (k units) Table 236. SAMEA Psychiatric API Sales by Type (2027-2032) & (k units) Table 237. SAMEA Psychiatric API Sales Price by Type (2021-2026) & (US$/unit) Table 238. SAMEA Psychiatric API Sales Price by Type (2027-2032) & (US$/unit) Table 239. SAMEA Psychiatric API Revenue by Application (2021-2026) & (US$ Million) Table 240. SAMEA Psychiatric API Revenue by Application (2027-2032) & (US$ Million) Table 241. SAMEA Psychiatric API Sales by Application (2021-2026) & (k units) Table 242. SAMEA Psychiatric API Sales by Application (2027-2032) & (k units) Table 243. SAMEA Psychiatric API Sales Price by Application (2021-2026) & (US$/unit) Table 244. SAMEA Psychiatric API Sales Price by Application (2027-2032) & (US$/unit) Table 245. SAMEA Psychiatric API Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 246. SAMEA Psychiatric API Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 247. SAMEA Psychiatric API Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 248. SAMEA Psychiatric API Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 249. SAMEA Psychiatric API Sales by Country (2021-2026) & (k units) Table 250. SAMEA Psychiatric API Sales by Country (2027-2032) & (k units) Table 251. SAMEA Psychiatric API Sales Price by Country (2021-2026) & (US$/unit) Table 252. SAMEA Psychiatric API Sales Price by Country (2027-2032) & (US$/unit) Table 253. Brazil Psychiatric API Revenue (2021-2032) & (US$ Million) Table 254. Argentina Psychiatric API Revenue (2021-2032) & (US$ Million) Table 255. Chile Psychiatric API Revenue (2021-2032) & (US$ Million) Table 256. Colombia Psychiatric API Revenue (2021-2032) & (US$ Million) Table 257. Peru Psychiatric API Revenue (2021-2032) & (US$ Million) Table 258. Saudi Arabia Psychiatric API Revenue (2021-2032) & (US$ Million) Table 259. Israel Psychiatric API Revenue (2021-2032) & (US$ Million) Table 260. UAE Psychiatric API Revenue (2021-2032) & (US$ Million) Table 261. Turkey Psychiatric API Revenue (2021-2032) & (US$ Million) Table 262. Iran Psychiatric API Revenue (2021-2032) & (US$ Million) Table 263. Egypt Psychiatric API Revenue (2021-2032) & (US$ Million) Table 264. Key Raw Materials Table 265. Raw Materials Key Suppliers Table 266. Psychiatric API Distributors List Table 267. Psychiatric API Customers List Table 268. Research Programs/Design for This Report Table 269. Authors List of This Report Table 270. Secondary Sources Table 271. Primary Sources List of Figures Figure 1. Psychiatric API Image Figure 2. Global Psychiatric API Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Psychiatric API Market Size Share 2021 VS 2025 VS 2032 Figure 4. Venlafaxine Image Figure 5. Paroxetine Image Figure 6. Duloxetine Image Figure 7. Olanzapine Image Figure 8. Others Image Figure 9. Global Psychiatric API Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Psychiatric API Market Size Share 2021 VS 2025 VS 2032 Figure 11. Generalized Anxiety Disorder Image Figure 12. Schizophrenia Image Figure 13. Fibromyalgia Image Figure 14. Major Depressive Disorder Image Figure 15. Others Image Figure 16. Global Psychiatric API Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Psychiatric API Revenue (2021-2032) & (US$ Million) Figure 18. Global Psychiatric API Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Psychiatric API Revenue Market Share by Region: 2025 Versus 2032 Figure 20. Global Psychiatric API Revenue Market Share by Region (2021-2032) Figure 21. Global Psychiatric API Sales (2021-2032) & (k units) Figure 22. Global Psychiatric API Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 23. Global Psychiatric API Sales Market Share by Region (2021-2032) Figure 24. US & Canada & Mexico Psychiatric API Sales YoY (2021-2032) & (k units) Figure 25. Europe Psychiatric API Sales YoY (2021-2032) & (k units) Figure 26. China Psychiatric API Sales YoY (2021-2032) & (k units) Figure 27. Asia (Excluding China) Psychiatric API Sales YoY (2021-2032) & (k units) Figure 28. South America, Middle East and Africa Psychiatric API Sales YoY (2021-2032) & (k units) Figure 29. Global Psychiatric API Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 30. Global Psychiatric API Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 31. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 32. Global Psychiatric API Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Psychiatric API Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Psychiatric API Revenue Market Share by Type (2021-2032) Figure 35. Global Psychiatric API Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 36. Global Psychiatric API Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 37. Global Psychiatric API Sales Market Share by Type (2021-2032) Figure 38. Global Psychiatric API Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 39. Global Psychiatric API Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Psychiatric API Revenue Market Share by Application (2021-2032) Figure 41. Global Psychiatric API Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 42. Global Psychiatric API Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 43. Global Psychiatric API Sales Market Share by Application (2021-2032) Figure 44. North America Psychiatric API Revenue Share by Type (2021-2032) Figure 45. North America Psychiatric API Sales Share by Type (2021-2032) Figure 46. North America Psychiatric API Revenue Share by Application (2021-2032) Figure 47. North America Psychiatric API Sales Share by Application (2021-2032) Figure 48. North America Psychiatric API Revenue Share by Country (2021-2032) Figure 49. North America Psychiatric API Sales Share by Country (2021-2032) Figure 50. Europe Psychiatric API Revenue Share by Type (2021-2032) Figure 51. Europe Psychiatric API Sales Share by Type (2021-2032) Figure 52. Europe Psychiatric API Revenue Share by Application (2021-2032) Figure 53. Europe Psychiatric API Sales Share by Application (2021-2032) Figure 54. Europe Psychiatric API Revenue Share by Country (2021-2032) Figure 55. Europe Psychiatric API Sales Share by Country (2021-2032) Figure 56. China Psychiatric API Revenue Share by Type (2021-2032) Figure 57. China Psychiatric API Sales Share by Type (2021-2032) Figure 58. China Psychiatric API Revenue Share by Application (2021-2032) Figure 59. China Psychiatric API Sales Share by Application (2021-2032) Figure 60. Asia Psychiatric API Revenue Share by Type (2021-2032) Figure 61. Asia Psychiatric API Sales Share by Type (2021-2032) Figure 62. Asia Psychiatric API Revenue Share by Application (2021-2032) Figure 63. Asia Psychiatric API Sales Share by Application (2021-2032) Figure 64. Asia Psychiatric API Revenue Share by Country (2021-2032) Figure 65. Asia Psychiatric API Sales Share by Country (2021-2032) Figure 66. SAMEA Psychiatric API Revenue Share by Type (2021-2032) Figure 67. SAMEA Psychiatric API Sales Share by Type (2021-2032) Figure 68. SAMEA Psychiatric API Revenue Share by Application (2021-2032) Figure 69. SAMEA Psychiatric API Sales Share by Application (2021-2032) Figure 70. SAMEA Psychiatric API Revenue Share by Country (2021-2032) Figure 71. SAMEA Psychiatric API Sales Share by Country (2021-2032) Figure 72. Psychiatric API Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Psychiatric API Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Venlafaxine
  • Paroxetine
  • Duloxetine
  • Olanzapine
  • Others
Applications
  • Generalized Anxiety Disorder
  • Schizophrenia
  • Fibromyalgia
  • Major Depressive Disorder
  • Others
Companies covered
  • Yaopharma
  • Yangtze River Pharmaceutical
  • Sichuan Chuanda West China Pharmaceutical
  • Ren An Pharmaceutical
  • Eli Lilly
  • Kanghong Pharmaceutical
  • Pfizer
  • Huahai Pharmaceutical
  • Hengrui Pharmaceuticals
  • Herui Pharmaceutical
  • Dongting Pharmaceutical
  • Brilliant Pharmaceutical
  • Salutas Pharma
  • Germany Pharmaceutical
  • Dr.Reddy's Laboratories
  • Bora Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Psychiatric API Market by Type
  3. 1.2.1 Global Psychiatric API Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Venlafaxine
  5. 1.2.3 Paroxetine
  6. 1.2.4 Duloxetine
  7. 1.2.5 Olanzapine
  8. 1.2.6 Others
  9. 1.3 Psychiatric API Market by Application
  10. 1.3.1 Global Psychiatric API Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Generalized Anxiety Disorder
  12. 1.3.3 Schizophrenia
  13. 1.3.4 Fibromyalgia
  14. 1.3.5 Major Depressive Disorder
  15. 1.3.6 Others
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Psychiatric API Market Dynamics
  1. 2.1 Psychiatric API Industry Trends
  2. 2.2 Psychiatric API Industry Drivers
  3. 2.3 Psychiatric API Industry Opportunities and Challenges
  4. 2.4 Psychiatric API Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Psychiatric API Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Psychiatric API Revenue by Region
  3. 3.2.1 Global Psychiatric API Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Psychiatric API Revenue by Region (2021-2026)
  5. 3.2.3 Global Psychiatric API Revenue by Region (2027-2032)
  6. 3.2.4 Global Psychiatric API Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Psychiatric API Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Psychiatric API Sales by Region
  9. 3.4.1 Global Psychiatric API Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Psychiatric API Sales by Region (2021-2026)
  11. 3.4.3 Global Psychiatric API Sales by Region (2027-2032)
  12. 3.4.4 Global Psychiatric API Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Psychiatric API Revenue by Manufacturers
  2. 4.1.1 Global Psychiatric API Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Psychiatric API Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Psychiatric API Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Psychiatric API Sales by Manufacturers
  6. 4.2.1 Global Psychiatric API Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Psychiatric API Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Psychiatric API Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Psychiatric API Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Psychiatric API Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Psychiatric API Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Psychiatric API Manufacturers, Product Type & Application
  13. 4.7 Global Psychiatric API Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Psychiatric API Market CR5 and HHI
  16. 4.8.2 2025 Psychiatric API Tier 1, Tier 2, and Tier 3
5 Psychiatric API Market by Type
  1. 5.1 Global Psychiatric API Revenue by Type
  2. 5.1.1 Global Psychiatric API Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Psychiatric API Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Psychiatric API Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Psychiatric API Sales by Type
  6. 5.2.1 Global Psychiatric API Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Psychiatric API Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Psychiatric API Sales Market Share by Type (2021-2032)
  9. 5.3 Global Psychiatric API Price by Type
6 Psychiatric API Market by Application
  1. 6.1 Global Psychiatric API Revenue by Application
  2. 6.1.1 Global Psychiatric API Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Psychiatric API Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Psychiatric API Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Psychiatric API Sales by Application
  6. 6.2.1 Global Psychiatric API Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Psychiatric API Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Psychiatric API Sales Market Share by Application (2021-2032)
  9. 6.3 Global Psychiatric API Price by Application
7 Company Profiles
  1. 7.1 Yaopharma
  2. 7.1.1 Yaopharma Company Information
  3. 7.1.2 Yaopharma Business Overview
  4. 7.1.3 Yaopharma Psychiatric API Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Yaopharma Psychiatric API Product Portfolio
  6. 7.1.5 Yaopharma Recent Developments
  7. 7.2 Yangtze River Pharmaceutical
  8. 7.2.1 Yangtze River Pharmaceutical Company Information
  9. 7.2.2 Yangtze River Pharmaceutical Business Overview
  10. 7.2.3 Yangtze River Pharmaceutical Psychiatric API Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Yangtze River Pharmaceutical Psychiatric API Product Portfolio
  12. 7.2.5 Yangtze River Pharmaceutical Recent Developments
  13. 7.3 Sichuan Chuanda West China Pharmaceutical
  14. 7.3.1 Sichuan Chuanda West China Pharmaceutical Company Information
  15. 7.3.2 Sichuan Chuanda West China Pharmaceutical Business Overview
  16. 7.3.3 Sichuan Chuanda West China Pharmaceutical Psychiatric API Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Sichuan Chuanda West China Pharmaceutical Psychiatric API Product Portfolio
  18. 7.3.5 Sichuan Chuanda West China Pharmaceutical Recent Developments
  19. 7.4 Ren An Pharmaceutical
  20. 7.4.1 Ren An Pharmaceutical Company Information
  21. 7.4.2 Ren An Pharmaceutical Business Overview
  22. 7.4.3 Ren An Pharmaceutical Psychiatric API Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Ren An Pharmaceutical Psychiatric API Product Portfolio
  24. 7.4.5 Ren An Pharmaceutical Recent Developments
  25. 7.5 Eli Lilly
  26. 7.5.1 Eli Lilly Company Information
  27. 7.5.2 Eli Lilly Business Overview
  28. 7.5.3 Eli Lilly Psychiatric API Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Eli Lilly Psychiatric API Product Portfolio
  30. 7.5.5 Eli Lilly Recent Developments
  31. 7.6 Kanghong Pharmaceutical
  32. 7.6.1 Kanghong Pharmaceutical Company Information
  33. 7.6.2 Kanghong Pharmaceutical Business Overview
  34. 7.6.3 Kanghong Pharmaceutical Psychiatric API Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Kanghong Pharmaceutical Psychiatric API Product Portfolio
  36. 7.6.5 Kanghong Pharmaceutical Recent Developments
  37. 7.7 Pfizer
  38. 7.7.1 Pfizer Company Information
  39. 7.7.2 Pfizer Business Overview
  40. 7.7.3 Pfizer Psychiatric API Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Pfizer Psychiatric API Product Portfolio
  42. 7.7.5 Pfizer Recent Developments
  43. 7.8 Huahai Pharmaceutical
  44. 7.8.1 Huahai Pharmaceutical Company Information
  45. 7.8.2 Huahai Pharmaceutical Business Overview
  46. 7.8.3 Huahai Pharmaceutical Psychiatric API Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Huahai Pharmaceutical Psychiatric API Product Portfolio
  48. 7.8.5 Huahai Pharmaceutical Recent Developments
  49. 7.9 Hengrui Pharmaceuticals
  50. 7.9.1 Hengrui Pharmaceuticals Company Information
  51. 7.9.2 Hengrui Pharmaceuticals Business Overview
  52. 7.9.3 Hengrui Pharmaceuticals Psychiatric API Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Hengrui Pharmaceuticals Psychiatric API Product Portfolio
  54. 7.9.5 Hengrui Pharmaceuticals Recent Developments
  55. 7.10 Herui Pharmaceutical
  56. 7.10.1 Herui Pharmaceutical Company Information
  57. 7.10.2 Herui Pharmaceutical Business Overview
  58. 7.10.3 Herui Pharmaceutical Psychiatric API Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Herui Pharmaceutical Psychiatric API Product Portfolio
  60. 7.10.5 Herui Pharmaceutical Recent Developments
  61. 7.11 Dongting Pharmaceutical
  62. 7.11.1 Dongting Pharmaceutical Company Information
  63. 7.11.2 Dongting Pharmaceutical Business Overview
  64. 7.11.3 Dongting Pharmaceutical Psychiatric API Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Dongting Pharmaceutical Psychiatric API Product Portfolio
  66. 7.11.5 Dongting Pharmaceutical Recent Developments
  67. 7.12 Brilliant Pharmaceutical
  68. 7.12.1 Brilliant Pharmaceutical Company Information
  69. 7.12.2 Brilliant Pharmaceutical Business Overview
  70. 7.12.3 Brilliant Pharmaceutical Psychiatric API Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Brilliant Pharmaceutical Psychiatric API Product Portfolio
  72. 7.12.5 Brilliant Pharmaceutical Recent Developments
  73. 7.13 Salutas Pharma
  74. 7.13.1 Salutas Pharma Company Information
  75. 7.13.2 Salutas Pharma Business Overview
  76. 7.13.3 Salutas Pharma Psychiatric API Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Salutas Pharma Psychiatric API Product Portfolio
  78. 7.13.5 Salutas Pharma Recent Developments
  79. 7.14 Germany Pharmaceutical
  80. 7.14.1 Germany Pharmaceutical Company Information
  81. 7.14.2 Germany Pharmaceutical Business Overview
  82. 7.14.3 Germany Pharmaceutical Psychiatric API Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Germany Pharmaceutical Psychiatric API Product Portfolio
  84. 7.14.5 Germany Pharmaceutical Recent Developments
  85. 7.15 Dr.Reddy's Laboratories
  86. 7.15.1 Dr.Reddy's Laboratories Company Information
  87. 7.15.2 Dr.Reddy's Laboratories Business Overview
  88. 7.15.3 Dr.Reddy's Laboratories Psychiatric API Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Dr.Reddy's Laboratories Psychiatric API Product Portfolio
  90. 7.15.5 Dr.Reddy's Laboratories Recent Developments
  91. 7.16 Bora Pharmaceutical
  92. 7.16.1 Bora Pharmaceutical Company Information
  93. 7.16.2 Bora Pharmaceutical Business Overview
  94. 7.16.3 Bora Pharmaceutical Psychiatric API Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Bora Pharmaceutical Psychiatric API Product Portfolio
  96. 7.16.5 Bora Pharmaceutical Recent Developments
8 North America
  1. 8.1 North America Psychiatric API Market Size by Type
  2. 8.1.1 North America Psychiatric API Revenue by Type (2021-2032)
  3. 8.1.2 North America Psychiatric API Sales by Type (2021-2032)
  4. 8.1.3 North America Psychiatric API Price by Type (2021-2032)
  5. 8.2 North America Psychiatric API Market Size by Application
  6. 8.2.1 North America Psychiatric API Revenue by Application (2021-2032)
  7. 8.2.2 North America Psychiatric API Sales by Application (2021-2032)
  8. 8.2.3 North America Psychiatric API Price by Application (2021-2032)
  9. 8.3 North America Psychiatric API Market Size by Country
  10. 8.3.1 North America Psychiatric API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Psychiatric API Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Psychiatric API Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Psychiatric API Market Size by Type
  2. 9.1.1 Europe Psychiatric API Revenue by Type (2021-2032)
  3. 9.1.2 Europe Psychiatric API Sales by Type (2021-2032)
  4. 9.1.3 Europe Psychiatric API Price by Type (2021-2032)
  5. 9.2 Europe Psychiatric API Market Size by Application
  6. 9.2.1 Europe Psychiatric API Revenue by Application (2021-2032)
  7. 9.2.2 Europe Psychiatric API Sales by Application (2021-2032)
  8. 9.2.3 Europe Psychiatric API Price by Application (2021-2032)
  9. 9.3 Europe Psychiatric API Market Size by Country
  10. 9.3.1 Europe Psychiatric API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Psychiatric API Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Psychiatric API Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Psychiatric API Market Size by Type
  2. 10.1.1 China Psychiatric API Revenue by Type (2021-2032)
  3. 10.1.2 China Psychiatric API Sales by Type (2021-2032)
  4. 10.1.3 China Psychiatric API Price by Type (2021-2032)
  5. 10.2 China Psychiatric API Market Size by Application
  6. 10.2.1 China Psychiatric API Revenue by Application (2021-2032)
  7. 10.2.2 China Psychiatric API Sales by Application (2021-2032)
  8. 10.2.3 China Psychiatric API Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Psychiatric API Market Size by Type
  2. 11.1.1 Asia Psychiatric API Revenue by Type (2021-2032)
  3. 11.1.2 Asia Psychiatric API Sales by Type (2021-2032)
  4. 11.1.3 Asia Psychiatric API Price by Type (2021-2032)
  5. 11.2 Asia Psychiatric API Market Size by Application
  6. 11.2.1 Asia Psychiatric API Revenue by Application (2021-2032)
  7. 11.2.2 Asia Psychiatric API Sales by Application (2021-2032)
  8. 11.2.3 Asia Psychiatric API Price by Application (2021-2032)
  9. 11.3 Asia Psychiatric API Market Size by Country
  10. 11.3.1 Asia Psychiatric API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Psychiatric API Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Psychiatric API Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Psychiatric API Market Size by Type
  2. 12.1.1 SAMEA Psychiatric API Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Psychiatric API Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Psychiatric API Price by Type (2021-2032)
  5. 12.2 SAMEA Psychiatric API Market Size by Application
  6. 12.2.1 SAMEA Psychiatric API Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Psychiatric API Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Psychiatric API Price by Application (2021-2032)
  9. 12.3 SAMEA Psychiatric API Market Size by Country
  10. 12.3.1 SAMEA Psychiatric API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Psychiatric API Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Psychiatric API Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Psychiatric API Value Chain Analysis
  2. 13.1.1 Psychiatric API Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Psychiatric API Production Mode & Process
  6. 13.2 Psychiatric API Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Psychiatric API Distributors
  9. 13.2.3 Psychiatric API Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst